Skip to content

Total Assets at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$26.48B+15.8%
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
$555.19M+1.2%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$724M+43.4%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$763.27M+198%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$789.02M+19.4%
Immunome logo
ImmunomeIMNM
$619.79M+80.9%

Other financials

Income statement

See full
Operating income-$125.1M-119%
Net income-$121.0M-134%
EPS (diluted)-$1.69-109%

Balance sheet

See full
Cash & equivalents$114.4M+108%
Total debt$75.0M+37.8%
Total equity$499.7M-6.6%

Cash flow

See full
Operating cash flow-$106.5M-95.8%
CapEx$23.0K-87.7%
Free cash flow-$106.5M-95.1%

Valuation

See full
Market cap$2.74B+87.5%
Enterprise value$2.7B+85.0%

Returns & leverage

See full
Return on equity-71.3%+296pp
Debt / equity0.2×0.0×
Current ratio13.6×-14.0×

Where this comes from

Reported directly by Vera Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Vera Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vera Therapeutics's total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vera Therapeutics's total assets?
Vera Therapeutics (VERA) reported total assets of $621.74M in Q1 2026.
How has Vera Therapeutics's total assets changed year-over-year?
Vera Therapeutics's total assets increased by 1.9% year-over-year, from $610.17M to $621.74M.
What is the long-term trend for Vera Therapeutics's total assets?
Over 5 years (2020 to 2025), Vera Therapeutics's total assets has grown at a 68.2% compound annual growth rate (CAGR), from $54.55M to $734.73M.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.